Emirates Drug Establishment Approves Innovative Treatment for Pulmonary Fibrosis
Dubai: The Emirates Drug Establishment (EDE) has granted regulatory approval for Jascayd® (nerandomilast), a treatment prescribed for Idiopathic Pulmonary Fibrosis (IPF) and Progressive Pulmonary Fibrosis (PPF) in adult patients. This decision is expe…